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An enantioselective and diastereoselective approach toward the synthesis of the polycyclic norditerpenoid
ineleganolide is disclosed. A palladium-catalyzed enantioselective allylic alkylation is employed to
stereoselectively construct the requisite chiral tertiary ether and facilitate the synthesis of a 1,3-cis-
cyclopentenediol building block. Careful substrate design enabled the convergent assembly of
the ineleganolide [6,7,5,5]-tetracyclic scaﬀold by a diastereoselective cyclopropanation–Cope
rearrangement cascade under unusually mild conditions. Computational evaluation of ground state
energies of late-stage synthetic intermediates was used to guide synthetic development and aid in the
investigation of the conformational rigidity of these highly constrained and compact polycyclic
structures. This work represents the ﬁrst successful synthesis of the core structure of any member of the
furanobutenolide-derived polycyclic norcembranoid diterpene family of natural products. Advanced
synthetic manipulations generated a series of natural product-like compounds that were shown to
possess selective secretory antagonism of either interleukin-5 or interleukin-17. This bioactivity stands in
contrast to the known antileukemic activity of ineleganolide and suggests the norcembranoid natural
product core may serve as a useful scaﬀold for the development of diverse therapeutics.Introduction
Target-directed synthesis provides an irreplaceable platform for
the invention of approaches to not only the structures of
interest, but also to previously unknown complex molecules of
potential biological importance. Our group has been fascinated
with the beautifully complex, highly oxygenated, and compact
polycyclic norcembranoid ineleganolide (1) since its initial
isolation in 1999 (Fig. 1).1 Over the following decades, the
subsequent isolation of sinulochmodin C (2)2 and a series of
closely related constitutional isomers (3–7)3 as well as the
disclosure of the biological activity of this family of nordi-
terpenoids (e.g. antileukemic activity of ineleganolide)1,3a,d,4 has
fortied our interest in the synthesis of these molecules.
Ineleganolide (1) poses a particularly formidable synthetic
challenge. Characterized by a fused [6,7,5]-carbocyclic core, the
natural product is constrained within a highly cupped cong-
uration by a bridging dihydrofuranone ring. The periphery offor Chemistry and Chemical Engineering,
ering, California Institute of Technology,
tolz@caltech.edu
SI) available: Experimental procedures,
y crystallographic data. CCDC 853379,
and crystallographic data in CIF or
c6sc03347d
hemistry 2017this rigid polycyclic scaﬀold is decorated with a network of nine
stereogenic centers, eight of which are contiguous.
Owing to intricate structural complexity found in these
isomeric norditerpenoids, no de novo synthetic method exists
that enables even the construction of the core scaﬀolding of any
member of the family.5 The only laboratory-furnished sample of
ineleganolide (1) was produced by Pattenden in 2011 throughFig. 1 Isomeric [6,7]- and [7,6]-norcembranoid diterpene natural
products (blue and red, respectively).
Chem. Sci., 2017, 8, 507–514 | 507
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View Article Onlinebiomimetic semisynthesis via transannular anionic cyclization
cascade (Scheme 1).6 Nicolaou,7 Frontier,8 and Romo9 were
unable to construct the carbocyclic core of ineleganolide
through the synthetic application of similar cyclization
cascades. Moeller sought to forge the ineleganolide skeleton
(10) through electrochemical macrocyclization, but could not
successfully construct the required cycloheptanone.10 The
Vanderwal group planned to construct the same C–C bond in
the nal stages of the synthetic route by intramolecular cycli-
zation through a latent oxocarbenium (i.e. triate 11).11 Repre-
senting the most advanced synthetic eﬀort toward
ineleganolide (1) to date, the prerequisite lactone epimerization
could not be accomplished despite exhaustive eﬀorts, thwarting
the synthetic strategy.Scheme 2 Retrosynthetic analysis of ineleganolide (1).Results and discussion
Exploring the retrosynthetic dissection of ineleganolide (1) with
an eye toward the isomeric norcembranoids, the common 1,3-
cis-cyclopentanediol moiety became an attractive synthon for
the development of a convergent and modiable synthetic
strategy. In contrast to the unsuccessful previous synthetic
strategies (cf. Scheme 1), which incorporate the dihydrofur-
anone ring at an early stage, we believed the late-stage intro-
duction of this heterocycle would facilitate construction of the
carbocyclic core. Thus, ineleganolide (1) was envisioned to arise
from enone 12 aer formation of the dihydrofuranone ring by
oxa-Michael addition (Scheme 2). Enone 12 would be synthe-
sized through selective olen oxidation of cycloheptadiene 13.
Cope rearrangement of divinylcyclopropane 14 would forge
tetracycle 13.12 Intramolecular cyclopropanation of a-diazoester
15 would construct cyclopropane 14. Cyclization precursor 15
would be assembled by the coupling of carboxylic acid 16 and
1,3-cis-cyclopentenediol 17.Scheme 1 Biomimetic semisynthesis and previous synthetic attempts
toward ineleganolide (1).
508 | Chem. Sci., 2017, 8, 507–514Starting with the preparation of diol 17, we adapted
a strategy based on our previously reported eﬃcient and highly
enantioselective synthesis of 1,3-cis-cyclopentenediol 22
(Scheme 3).13 Using a palladium-catalyzed enantioselective
allylic alkylation to form the chiral tertiary ether, silyl enol ether
18 was transformed into ketone 21 in 82% yield with 92%
enantiomeric excess (ee). Judicious choice of the chiral ligand,
the more readily available and cost-eﬀective (S)-t-BuPHOX ((S)-
20) provided chiral tertiary ether 21 in the (S)-conguration. A
series of substrate-controlled diastereoselective trans-
formations from ketone 21 then provided diol 22 in ve steps,
which serves as a building block for norcembranoids in the
non-natural enantiomeric series (cf. Fig. 1).14 Methylenation of
diol 22 aﬀorded diene 23 in near-quantitative yield. Ultimately,
saponication of ester 23 furnished diol coupling partner ent-17
in a combined 63% yield over 9 steps from enol ether 18.
Construction of the complementary carboxylic acid fragment
(ent-16) began with (R)-desmethylcarvone ((R)-24, Scheme 4).15
The 1,2-addition of lithium enolate 25 under cerium-mediated
reaction conditions followed by oxidative 1,3-allylic trans-
position of the intermediate allylic alcohol with oxoammonium
salt TEMPO$BF4 (ref. 16) provided cyclohexenone 26. Saponi-
cation of ethyl ester 26 followed by coupling with diol fragment
ent-17 and diazotransfer using p-ABSA (27) provided the pivotalScheme 3 Enantioselective synthesis of 1,3-cis-cyclopentenediol
coupling partner ent-17.
This journal is © The Royal Society of Chemistry 2017
Scheme 4 Convergent assembly of the ineleganolide [6,7,5,5]-tetra-
cyclic core.
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View Article Onlinetandem cyclization cascade precursor, a-diazoester ent-15 in
75% yield over three steps.
Pleasingly, initial attempts to accomplish the planned
sequential intramolecular cyclopropanation–Cope rearrange-
ment demonstrated that the transformation proceeded eﬃ-
ciently under mild conditions. Exposure of a-diazoester ent-15
to catalytic dirhodium tetraacetate (1 mol%) in dichloro-
methane at ambient temperature enabled the construction of
cycloheptadiene 28, containing the complete carbocyclic core of
ent-ineleganolide (ent-1).17 This cyclization cascade is notable
given that it is completed under high dilution in less than
20 minutes at ambient temperature and employs an electroni-
cally deactivated olen in the [3,3]-sigmatropic rearrangement.
While examples of divinylcyclopropane rearrangements with
electron-neutral and electron-rich olens are abundant,12,18
those employing conjugated olens are limited and typically
require forcing conditions.12c,19
We speculate that the deleterious eﬀect of an electronically
deactivated p-bond in the sequential Cope rearrangement is
mitigated by substrate design. Cleavage of highly strained
bridging cyclopropane ent-14 upon isomerization to the cyclo-
heptadiene product ent-13 is associated with an increased
enthalpic gain compared to a prototypical cyclopropane-fused
Cope rearrangement that employs an isolated carbocycle.20
Additionally, the unsubstituted vinyl group contributes
minimal steric hindrance within the bis-endo conguration (cf.
ent-14, Scheme 4) and highly organized boat-like transition
state required for the cis-divinylcyclopropane rearrangement to
proceed.12a,21
Although the construction of the carbocyclic core of ent-
ineleganolide (ent-1) proceeds smoothly from a-diazoester ent-
15, no trace of the anticipated diene product (ent-13) was ever
detected. Rather, a,b-unsaturated enone 28 was isolated from
the reaction mixture as the exclusive product. The 1,3-allylicThis journal is © The Royal Society of Chemistry 2017isomerization is proposed to occur through a base-mediated
olen migration. g-Deprotonation of a,b-unsaturated ester ent-
13 by adventitious acetate and formation of an intermediate
conjugated enolate facilitates this process. We hypothesize this
isomerization is further aided by a relief of ring strain. These
assertions are supported by the observation of an analogous
olen migration under similarly basic reaction conditions.22
Installation of the nal requisite atom of ent-ineleganolide
was accomplished by a hydroxyl-directed epoxidation of tetra-
cycle 28 to provide epoxide 29 in 85% yield as a crystalline white
solid, enabling the conrmation of the relative conguration by
single crystal X-ray diﬀraction (Scheme 5). Henceforth known as
ent-isoineleganolide A, epoxide 29 is the rst known synthetic
isomer of ent-ineleganolide (ent-1) that: (1) contains the full
carbocyclic skeleton, (2) possesses all of the required atoms,
and (3) has an identical overall oxidation state.
The direct transformation of ent-isoineleganolide A (29) into
enone ent-12 was planned via syn-facial 1,2-hydride migration,
but this approach proved unsuccessful despite exhaustive
investigation.23 Instead, alternative access to tetracycle ent-12
was developed through the nucleophilic opening of the epoxide
moiety within ent-isoineleganolide A (29). This ring opening
proceeded with concomitant transannular oxa-Michael addi-
tion to furnish bromide 30 in near-quantitative yield. Gratify-
ingly, direct oxidation of the secondary alkyl bromide could be
aﬀected through a Kornblum oxidation manifold,24 aﬀording
diketone 31 in 96% yield.
This eﬃcient transformation stands in stark contrast against
canonical examples of oxidation under Kornblum conditions.
Substrates are usually limited to primary or benzylic halides;
only rare and uniformly low yielding examples of the successful
Kornblum oxidation of an unactivated secondary halide areScheme 5 Synthesis of ent-isoineleganolides A and B.
Chem. Sci., 2017, 8, 507–514 | 509
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View Article Onlinefound.24b,25 We hypothesize that the bridging furyl oxygen is
critical for this transformation, aiding in the abstraction of the
secondary bromide and stabilization of the intermediate car-
bocation (cf. 33, Scheme 5). Indeed, the analog lacking the furyl
tether fails to produce any trace of oxidation product under
similar conditions.26
Pleased to have achieved access to ketopyran 31, we refo-
cused our attention on advancement toward ent-ineleganolide
(ent-1). Chemoselective reduction of ketopyran 31 was observed
by tuning the reduction potential of samarium(II) iodide using
lithium chloride as an additive.27 Under these conditions, in situ
generated SmCl2 cleaves the a-alkoxyketone bond to provide
tetracyclic diol 32. Installation of the hydrogen from the a-face
upon protonation of the intermediate Sm-enolate was
conrmed by single crystal X-ray diﬀraction. This stereochem-
ical outcome provides the C(7) conguration found within ent-
ineleganolide. Selective dehydration of diol 32 under acidic
conditions provided the desired enone (ent-12), another non-
natural isomer of ent-ineleganolide (ent-isoineleganolide B).
Although we were optimistic this isomer would proceed to
ent-ineleganolide (ent-1) spontaneously by tandem olen
isomerization-oxa-Michael addition, this outcome was not
observed. Therefore, with enone ent-12 in hand, this trans-
formation was investigated in a stepwise manner. Despite
intensive eﬀorts to accomplish the isomerization of tetrasub-
stituted enone ent-12 to vinylogous diketone 34 (Scheme 6), no
trace of either intermediate 34 or ent-ineleganolide (ent-1) was
ever detected.28 Surprised by the lack of productive reactivity,
density functional theory (DFT) was used to explore the ther-
modynamics of the desired transformation.29 ent-Iso-
ineleganolide B (ent-12) likely exists in the conformation as
shown in Scheme 6 (le).30 In this conguration, the iso-
propenyl group prefers the pseudoequatorial position and the
central cycloheptenone is creased, bisecting the molecule.
Relative to the ground state energy of this intermediate, the
ground state energy of vinylogous diketone 34 is 13.4 kcal mol1
higher in its lowest energy product-like conformation, which
posits a pseudoaxial isopropenyl moiety and isomerized cyclo-
heptenone. However, the ground state energy of the natural
product (ent-1) in its known conguration1 is 14.2 kcal mol1
lower than vinylogous diketone 34 and overall 0.8 kcal mol1
lower in energy than ent-isoineleganolide B (ent-12).Scheme 6 Conformational assessment and relative ground state
energies.
510 | Chem. Sci., 2017, 8, 507–514The large ground state energy diﬀerence between tetra-
substituted enone ent-12 and vinylogous diketone 34 in addi-
tion to the empirical evidence for the inability to accomplish the
desired olen isomerization in the laboratory suggest the
energy barrier for the conversion from enone ent-12 to diketone
34 is experimentally insurmountable. This is likely due to the
large conformational shi required for the isomerization event
and the reduced enthalpic stability of the conjugated system.
The necessary contortion of the central cycloheptenone renders
production of the fully conjugated vinylogous diketone moiety
unfeasible. The comparative minimum ground state energy of
the natural product (ent-1) and the large exergonic diﬀerence
compared to vinylogous diketone 34 reinforced the use of this
intermediate in continued synthetic eﬀorts.
Toward this end, the oxidation state manipulation of
carbocyclic diene core 28 was explored (Scheme 7). Although
conjugate reduction of enone 28 could not be accomplished
using nucleophilic hydride sources, development of samar-
ium(II) iodide-mediated reaction conditions, including careful
control of reaction temperature and sensible selection of addi-
tive, enabled diastereoselective conjugate reduction to provide
allylic alcohol 35.27 Subsequent hydroxyl-directed epoxidation
aﬀorded saturated ketone 36 as a crystalline white solid. The
relative conguration of epoxide 36 was established by single
crystal X-ray diﬀraction analysis, conrming the installation of
the [6,7]-ring junction in the thermodynamically preferred trans
conguration identical to that found within ent-ineleganolide
(ent-1). As anticipated, application of the previously developed
three step Kornblum oxidation procedure for the conversion of
epoxide 36 to ketone 37 failed in the absence of the trans-
annular furyl bridge (vide supra), forcing a strategic
revaluation.26
In place of a nucleophilic epoxide opening, methods for
a radical-mediated reductive epoxide cleavage were investi-
gated. Employing in situ generated titanocene(III) chloride using
zinc metal as the optimal reductant, epoxide 36 was opened in
regioselective fashion to give the 1,3-diol product.31 ElaborationScheme 7 Redox manipulation of diene 28.
This journal is © The Royal Society of Chemistry 2017
Fig. 3 Biological activity of select ineleganoloids.
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
A
ug
us
t 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
9/
12
/2
01
6 
17
:2
5:
42
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineto the cycloheptanone was accomplished by oxidation of the
newly revealed secondary alcohol to provide 2H-ent-inelegano-
lide (37) in 33% yield in only two steps from epoxide 36.
The intermediacy of a tertiary radical at C(7) aer the C–O
bond scission, in analogous fashion to the reductive opening of
ketopyran 31 (see Scheme 5), enabled the installation of the
hydrogen on the a-face as desired. Single crystal X-ray diﬀrac-
tion served not only to conrm the assignment of this relative
conguration, but also revealed the conformational similarities
between 2H-ent-ineleganolide (37) and ent-ineleganolide (cf. ent-
1, Scheme 6). 2H-ent-Ineleganolide (37) contains the trans-[6,7]-
ring junction, with the isopropenyl substituent in the axial
position, and all required stereocenters and functional moieties
except the dihydrofuranone bridge. Unfortunately, the conver-
sion of 2H-ent-ineleganolide (37) to ent-ineleganolide (ent-1)
proved nontrivial. Formation of the nal requisite bond
through Sua´rez reaction,32 selenoxide elimination, palladium-
mediated oxidative desaturation33 or by employing either lea-
d(IV) acetate or hypervalent iodine reagents34 failed to produce
any traces of oxidation at the apical cycloheptanone methylene.
Surprised by the diﬃculty of functionalizing the central
cycloheptanone within 2H-ent-ineleganolide (37), we again
turned to computational chemistry. The solid-state conforma-
tion of 2H-ent-ineleganolide (37AAx, Fig. 2), determined by
single crystal X-ray diﬀraction, revealed the prototypical
conformation encountered throughout our synthetic endeavors
(e.g. 29, Scheme 5 and ent-12, Scheme 6). Conformational
isomerization of the isopropenyl moiety into the equatorial
position (37AAx/ 37Aequ) increases the ground state energy by
1.0 kcal mol1. Comparatively, the energy minimized confor-
mations 37Bax and 37Bequ, in which 2H-ent-ineleganolide has
adopted the natural product-like conguration within the
central cycloheptanone (cf. ent-1, Scheme 6),1 are slightly lower.
Although the lowest energy conformations of each state (37Aax
vs. 37Bax) are equivalent within the error of the computational
method, empirical evidence for the diﬃculty of functionalizing
the apical cycloheptanone methylene suggests that there is
a large energy barrier that hinders the interconversion between
these conformational isomers. Further computational studies
are being pursued in order to more completely understand the
energetics of the desired transformation.
Throughout the course of these studies, a reasonably large
collection of natural-product like compounds was generated.
Owing to the known antileukemic properties of ineleganolide,
these “ineleganoloids,” in the non-natural enantiomeric series,Fig. 2 Conformational isomers of 2H-ent-ineleganolide.
This journal is © The Royal Society of Chemistry 2017were evaluated for their activity in DU145 (human prostate
cancer) and A2038 (human melanoma) cell viability assays35 as
well as against other oncological targets (EZH2 (ref. 36) and
CD73 (ref. 37)). Although no notable activity toward any onco-
logical target was discovered, the concurrent screening of this
library for activity against targets in other therapeutic areas (i.e.,
neurological, cardiological, autoimmune, and endocrine func-
tion) revealed activity of various ineleganoloids.38 Diene 28,
bromide 30, ketopyran 31, and epoxide 36 were identied as
selective interleukin-5 or -17 (IL-5 and IL-17, respectively)
secretory inhibitors without signicant cytotoxicity (Fig. 3).39
Both IL-5 and IL-17 represent attractive pharmaceutical targets
considering their pivotal role in autoimmune response and
autoimmune disease (e.g., rheumatoid arthritis).40 The activity
of the ineleganoloids stands in stark contrast with the inability
of ineleganolide (1) to inhibit cytokine release.3a Further
investigation of these preliminary results is ongoing and
assessment of the biological activity of the ineleganoloids in the
natural enantiomeric series will follow in due course.Conclusions
In conclusion, an eﬃcient enantioselective and diaster-
eoselective synthetic route to the tetracyclic core of inelegano-
lide has been disclosed. Convergent assembly of the core
scaﬀold was accomplished by the coupling of two enantioen-
riched fragments, including a 1,3-cis-cyclopentenediol building
block common to the polycyclic norcembranoid diterpenes.
Tandem intramolecular cyclopropanation–Cope cyclization
cascade enabled the diastereoselective construction of the tet-
racyclic [6,7,5,5]-scaﬀold of ineleganolide in a single step,
providing synthetic access to the core of the polycyclic nor-
cembranoid diterpenes for the rst time. Guided by computa-
tional data, synthetic advancement facilitated the construction
of the rst synthetic isomers and analogs of ineleganolide.
These natural product-like ineleganoloids advanced the
understanding of the conformational restraints inuencing
chemistry of the highly compact norcembranoid diterpene
scaﬀold and have led to the identication of biologically active
ineleganolide analogs.Chem. Sci., 2017, 8, 507–514 | 511
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
A
ug
us
t 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
9/
12
/2
01
6 
17
:2
5:
42
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineAcknowledgements
The authors wish to thank the NIH-NIGMS (R01GM080269),
Amgen, the Gordon and Betty Moore Foundation, and Caltech
for nancial support and Eli Lilly & Co. for assistance with
biological activity screening. Additionally, the authors gratefully
acknowledge Larry Henling and Dr Michael Takase (Caltech) for
X-ray crystallographic structural determination, Dr Mona
Shahgholi and Naseem Torian (Caltech) for mass spectrometry
assistance, and Dr David VanderVelde (Caltech) for NMR
experimental assistance and helpful discussions. Additionally,
Dr Jeﬀrey C. Holder, Dr Corey M. Reeves, Prof. Hosea M. Nelson,
Dr Jonny R. Gordon, Dr Pamela M. Tadross, and Beau
P. Pritchett (Caltech) and Dr Ryan Deluca and Dr Nick Cox
(Stanford) are thanked for helpful discussions. R. A. C. grate-
fully acknowledges the support of this work provided by
a fellowship from the National Cancer Institute of the National
Institutes of Health (NIH) under Award Number F31A17435. J.
L. R. thanks the California Tobacco-Related Disease Research
Program of the University of California, Grant Number 14DT-
0004 for a predoctoral fellowship. A. C. J. thanks the NIH for the
support of this work provided by a postdoctoral fellowship
(Award Number F32GM082000).Notes and references
1 C.-Y. Duh, S.-K. Wang, M.-C. Chia and M. Y. Chiang,
Tetrahedron Lett., 1999, 40, 6033.
2 Y.-J. Tseng, A. F. Ahmed, C.-F. Dai, M. Y. Chiang and
J.-H. Sheu, Org. Lett., 2005, 7, 3813.
3 (a) K.-E. Lillsunde, C. Festa, H. Adel, S. de Marino,
V. Lombardi, S. Tilvi, D. Nawrot, A. Zampella, L. D'Souza,
M. D'Auria and P. Tammela, Mar. Drugs, 2014, 12, 4045; (b)
P. Radhika, P. V. Subba Rao, V. Anjaneyulu, R. N. Asolkar
and H. Laatsch, J. Nat. Prod., 2002, 65, 737; (c) J.-H. Sheu,
A. F. Ahmed, R.-T. Shiue, C.-F. Dai and Y.-H. Kuo, J. Nat.
Prod., 2002, 65, 1904; (d) K. Iguchi, K. Kajiyama and
Y. Yamada, Tetrahedron Lett., 1995, 36, 8807.
4 (a) C.-Y. Huang, Y.-J. Tseng, U. Chokkalingam, T.-L. Hwang,
C.-H. Hsu, C.-F. Dai, P.-J. Sung and J.-H. Sheu, J. Nat. Prod.,
2016, 79, 1339; (b) Y.-J. Tseng, S.-K. Wang and C.-Y. Duh,
Mar. Drugs, 2013, 11, 3288; (c) K.-J. Huang, Y.-C. Chen,
M. El-Shazly, Y.-C. Du, J.-H. Su, C.-W. Tsao, W.-H. Yen,
W.-B. Chang, Y.-D. Su, Y.-T. Yeh and M.-C. Lu, Molecules,
2013, 18, 2924; (d) H. N. Kamel and M. Slattery, Pharm.
Biol., 2005, 43, 253.
5 While most synthetic eﬀorts toward the polycyclic
norcembranoids have been focused on ineleganolide (1),
one attempt was made to synthesize the core of yonarolide
(5), see: Y. Ueda, H. Abe, K. Iguchi and H. Ito, Tetrahedron
Lett., 2011, 52, 3379.
6 (a) Y. Li and G. Pattenden, Tetrahedron, 2011, 67, 10045; (b)
Y. Li and G. Pattenden, Nat. Prod. Rep., 2011, 28, 1269; (c)
Y. Li and G. Pattenden, Nat. Prod. Rep., 2011, 28, 429.
7 B. A. Pratt, Ph.D. dissertation, Scripps Research Institute, La
Jolla, California, 2008.512 | Chem. Sci., 2017, 8, 507–5148 (a) C. O'Connell, Ph.D. dissertation, Queen's Universtiy of
Belfast, Belfast, Northern Ireland, U.K., 2006; (b)
C. E. O'Connell and A. J. Frontier, Abstracts of Papers, 32nd
Northeast Regional Meeting of the American Chemical Society,
American Chemical Society, Rochester, NY, October
31November 3 2004, GEN-088.
9 (a) G. Liu, Ph.D. dissertation, Texas A&M University, College
Station, Texas, 2011; (b) G. Liu, and D. Romo, Abstracts of
Papers, 237th American Chemical Society National Meeting,
American Chemical Society, Salt Lake City, UT, March
2226 2009, ORGN-083.
10 (a) F. Tang, Ph.D. dissertation, Washington University in St.
Louis, St. Louis, Missouri, 2009; (b) F. Tang and
K. D. Moeller, Tetrahedron, 2009, 65, 10863; (c) F. Tang and
K. D. Moeller, J. Am. Chem. Soc., 2007, 129, 12414.
11 (a) E. J. Horn, J. S. Silverston and C. D. Vanderwal, J. Org.
Chem., 2016, 81, 1819; (b) E. J. Horn, Ph.D. dissertation,
University of California at Irvine, Irvine, CA, 2014.
12 (a) S. Kru¨ger and T. Gaich, Beilstein J. Org. Chem., 2014, 10,
183; (b) H. M. L. Davies, D. G. Staﬀord, B. D. Doan and
J. H. Houser, J. Am. Chem. Soc., 1998, 120, 3326; (c)
H. M. L. Davies, Tetrahedron, 1993, 49, 5203; (d) E. Vogel,
Angew. Chem., Int. Ed., 1963, 2, 1.
13 R. A. Craig II, J. L. Roizen, R. C. Smith, A. C. Jones and
B. M. Stoltz, Org. Lett., 2012, 14, 5716.
14 The naturally occurring enantiomers of ineleganolide (1)
and the related norcembranoid diterpenes (2–7) were
originally established by analogy to the known absolute
stereochemistry of sinulochmodin C (2, see ref. 2). The
natural enantiomers of norditerpenoids 1–7 could be
accessed using (R)-t-BuPHOX ((R)-20), which has been
synthesized and used by our group in the enantioselective
total synthesis of (+)-liphagal, see: J. J. Day,
R. M. McFadden, S. C. Virgil, H. Kolding, J. L. Alleva and
B. M. Stoltz, Angew. Chem., Int. Ed., 2011, 50,
6814. Alternatively, more cost-eﬀective PHOX ligands
derived (R)-valine have been shown to be comparably
eﬀective to (R)-t-BuPHOX for the enantioselective
formation of ketone 21 from enol ether 18, see: R. A. Craig
II and B. M. Stoltz, Tetrahedron Lett., 2015, 56, 4670.
15 (R)-Desmethylcarvone ((R)-24) is available in 6 steps from
(R)-carvone, see: (a) M. A. Gonza´lez, S. Ghosh, F. Rivas,
D. Fischer and E. A. Theodorakis, Tetrahedron Lett., 2004,
45, 5039; (b) J. Chen and J. N. Marx, Tetrahedron Lett.,
1997, 38, 1889; (c) J.-F. Lavalle´e, C. Spino, R. Ruel,
K. T. Hogan and P. Deslongchamps, Can. J. Chem., 1991,
70, 1406.
16 M. Shibuya, M. Tomizawa and Y. Iwabuchi, J. Org. Chem.,
2008, 73, 4750.
17 Although no trace of cyclopropane ent-14 has been detected
during the conversion of a-diazoester ent-15 to
cycloheptadiene 28, the isolation of cyclopropane I and the
subsequent step-wise advancement to cycloheptadiene II
supports the assertion that a tandem cyclopropanation–
Cope rearrangement cascade is operative. Without isolated
intermediates, however, we are unable to conclusively rule
out the formation of cycloheptadiene product 28 throughThis journal is © The Royal Society of Chemistry 2017
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
A
ug
us
t 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
9/
12
/2
01
6 
17
:2
5:
42
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinea direct (4 + 3) cycloaddition from a-diazoester ent-15, see:
P. E. Guzma´n, Y. Lian and H. M. L. Davies, Angew. Chem.,
Int. Ed., 2014, 53, 13083.
18 (a) M. Gaydou, R. E. Miller, N. Delpont, J. Ceccon and
A. M. Echavarren, Angew. Chem., Int. Ed., 2013, 52, 6396;
(b) R. G. Vaswani, J. J. Day and J. L. Wood, Org. Lett., 2009,
11, 4532; (c) H. M. L. Davies, R. L. Calvo, R. J. Townsend,
P. Ren and R. M. Churchill, J. Org. Chem., 2000, 65, 4261;
(d) A. S. Kende, T. L. Smalley Jr and H. Huang, J. Am.
Chem. Soc., 1999, 121, 7431.
19 (a) J. D. Osler, W. P. Unsworth and R. J. K. Taylor, Org.
Biomol. Chem., 2013, 11, 7587; (b) H. Ito, S. Takeguchi,
T. Kawagishi and K. Iguchi, Org. Lett., 2006, 8, 4883; (c)
T. Fukuyama and G. Liu, J. Am. Chem. Soc., 1996, 118,
7426; (d) P. A. Wender, M. A. Eissenstat and M. P. Filosa, J.
Am. Chem. Soc., 1979, 101, 2196.
20 For comparisons of the strain energy of isolated
cyclopropaneswith fused cyclopropane ring systems, see:
(a) M. L. G. Borst, A. W. Ehlers and K. Lammertsma, J. Org.
Chem., 2005, 70, 8110; (b) K. B. Wiberg, S. R. Kass, A. de
Meijere and K. C. Bishop III, J. Am. Chem. Soc., 1985, 107,
1003.
21 (a) M. Zora, J. Mol. Struct.: THEOCHEM, 2004, 681, 113; (b)
M. Zora, J. Org. Chem., 2003, 68, 9635; (c) M. Zora, I. O¨zkan
and M. F. Danis¸man, J. Mol. Struct.: THEOCHEM, 2003,
636, 9; (d) W. V. E. Doering and W. R. Roth, Angew. Chem.,
Int. Ed., 1963, 2, 115.
22 Oxidation of diol III resulted in reformation of
isoineleganolide A (29) aer olen migration in the
presence of the adventitious acetate byproduct derived
from Dess-Martin periodinane.
23 A characteristic list of the conditions attempted to induce
the desired epoxide isomerization: H2SO4/CHCl3, SiO2/
CHCl3, DBU/CHCl3, KOt-Bu/THF, Pd(CH3CN)2Cl2/benzene,
BF3$Et2O/CHCl3, In(OTf)3/CHCl3, Al(Oi-Pr)3/CHCl3, Ti(Oi-
Pr)4/THF, Zn(OTf)2/toluene, Mg(OTf)2/toluene, MgCl2/
toluene, MgBr2/toluene.
24 (a) T. W. Ly, J.-H. Liao, K.-S. Shia and H.-J. Liu, Synthesis,
2004, 271; (b) B. Ganem and R. K. Boeckman Jr,
Tetrahedron Lett., 1974, 15, 917; (c) N. Kornblum,
W. J. Jones and G. J. Anderson, J. Am. Chem. Soc., 1959, 81,
4113.
25 (a) H.-J. Liu and D. Sun, Tetrahedron Lett., 1997, 38, 6159; (b)
P. Dave, H.-S. Byun and R. Engel, Synth. Commun., 1986, 16,
1343.This journal is © The Royal Society of Chemistry 201726 Under analogous Kornblum oxidation conditions, bromide
IV fails to undergo any oxidative transformation. In fact,
bromide IV does not react until heated above 120 C, at
which point only dehydration of the substrate is observed.
27 (a) M. Szostak, M. Spain and D. J. Procter, J. Org. Chem.,
2014, 79, 2522; (b) S. E. Reisman, J. M. Ready,
M. M. Weiss, A. Hasuoka, M. Hirata, K. Tamaki,
T. V. Ovaska, C. J. Smith and J. L. Wood, J. Am. Chem. Soc.,
2006, 128, 1448; (c) R. S. Miller, J. M. Sealy, M. Shabangi,
M. L. Kuhlman, J. R. Fuchs and R. A. Flowers, J. Am. Chem.
Soc., 2000, 122, 7718.
28 A characteristic list of the conditions attempted to induce
the desired olen isomerization: DBU/CH2Cl2,
PdCl2(CH3CN)2/CH2Cl2, Grubbs Gen. II/MeOH, RhCl3$H2O/
EtOH, LHMDS/THF.
29 Calculations were performed with Spartan '10
(Wavefunction, Inc., Irvine, CA). The in vacuo equilibrium
geometry for each structure was calculated by a series of
sequential calculations as follows: Hartree–Fock
computation (equilibrium geometry, 3-21G basis set), DFT
(equilibrium geometry, B3LYP/6-31G basis set), DFT
(energy, B3LYP/6-311+G** basis set), DFT (equilibrium
geometry, B3LYP/6-311+G** basis set). The error from
these calculations is 0.23 kcal mol1, thus all energy
diﬀerences larger than 0.46 kcal mol1 were considered
signicant. Except for molecular mechanics and semi-
empirical models, the calculation methods used in Spartan
have been documented in: Y. Shao, L. F. Molnar, Y. Jung,
J. Kussmann, C. Ochsenfeld, S. T. Brown, A. T. B. Gilbert,
L. V. Slipchenko, S. V. Levchenko, D. P. O'Neill,
R. A. DiStasio Jr, R. C. Lochan, T. Wang, G. J. O. Beran,
N. A. Besley, J. M. Herbert, C. Y. Lin, T. Van Voorhis,
S. H. Chien, A. Sodt, R. P. Steele, V. A. Rassolov,
P. E. Maslen, P. P. Korambath, R. D. Adamson, B. Austin,
J. Baker, E. F. C. Byrd, H. Dachsel, R. J. Doerksen,
A. Dreuw, B. D. Dunietz, A. D. Dutoi, T. R. Furlani,
S. R. Gwaltney, A. Heyden, S. Hirata, C.-P. Hsu,
G. Kedziora, R. Z. Khalliulin, P. Klunzinger, A. M. Lee,
M. S. Lee, W. Z. Liang, I. Lotan, N. Nair, B. Peters,
E. I. Proynov, P. A. Pieniazek, Y. M. Rhee, J. Ritchie,
E. Rosta, C. D. Sherrill, A. C. Simmonett, J. E. Subotnik,
H. L. Woodcock III, W. Zhang, A. T. Bell,
A. K. Chakraborty, D. M. Chipman, F. J. Keil, A. Warshel,
W. J. Hehre, H. F. Schaefer III, J. Kong, A. I. Krylov,
P. M. W. Gill and M. Head-Gordon, Phys. Chem. Chem.
Phys., 2006, 8, 3172.
30 The conformation of ent-isoineleganolide B (ent-12) was
established by two-dimensional NOE studies and by
analogy to the conformation of precursors 28–32, as
established by single crystal X-ray diﬀraction. The ground
state energies of the other conformations of ent-Chem. Sci., 2017, 8, 507–514 | 513
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
7 
A
ug
us
t 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
9/
12
/2
01
6 
17
:2
5:
42
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineisoineleganolide B (ent-12) were additionally assessed by our
computational method and are all within 1.8 kcal mol1 of
one another. For full details, see ESI.†
31 (a) T. Jime´nez, A. G. Campan˜a, B. Bazdi, M. Paradas,
D. Arra´ez-Roma´n, A. Segura-Carretero, A. Ferna´ndez-
Gutie´rrez, J. E. Oltra, R. Robles, J. Justicia and
J. M. Cuerva, Eur. J. Org. Chem., 2010, 4288; (b)
A. Gansa¨uer, M. Pierobon and H. Bluhm, Angew. Chem.,
Int. Ed., 1998, 37, 101; (c) T. V. RajanBabu and
W. A. Nugent, J. Am. Chem. Soc., 1994, 116, 986; (d)
T. V. RajanBabu, W. A. Nugent and M. S. Beattie, J. Am.
Chem. Soc., 1990, 112, 6408.
32 (a) C. Betancor, R. Freire, I. Pe´rez-Mart´ın, T. Prange´ and
E. Sua´rez, Tetrahedron, 2005, 61, 2803; (b) P. de Armas,
J. I. Concepcio´n, C. G. Francisco, R. Herna´ndez,
J. A. Salazar and E. Sua´rez, J. Chem. Soc., Perkin Trans. 1,
1989, 405; (c) J. I. Concepcio´n, C. G. Francisco,
R. Herna´ndez, J. A. Salazar and E. Sua´rez, Tetrahedron
Lett., 1984, 25, 1953.
33 A wide variety of conditions were screened for palladium-
meditated oxidative desaturation both directly from ketone
37 as well as stepwise through the intermediate silyl enol
ether without success. For select examples, see: (a) T. Diao
and S. S. Stahl, J. Am. Chem. Soc., 2011, 133, 14566; (b)
N. Ohmori, J. Chem. Soc., Perkin Trans. 1, 2002, 755; (c)
S. J. Degrado, H. Mizutani and A. H. Hoveyda, J. Am. Chem.
Soc., 2001, 123, 755.
34 Eﬀorts were focused on the application of 2-iodoxybenzoic
acid (IBX) and PhI(OH)(OTs), see: (a) K. C. Nicolaou,
T. Montagnon, P. S. Baran and Y. L. Zhong, J. Am. Chem.514 | Chem. Sci., 2017, 8, 507–514Soc., 2002, 124, 2245; (b) R. M. Moriarty, R. K. Vaid,
T. E. Hopkins, B. K. Vaid and O. Prakash, Tetrahedron Lett.,
1990, 31, 201.
35 Compounds 28, 29, 30, 31, and 32 were screened against
DU145 and A2038 cell viability assays in triplicate,
revealing no signicant activity. Special, personal thanks to
Prof. David Horne and Prof. Sangkil Nam (City of Hope,
Duarte, CA) for their assistance in performing these cell
viability assays.
36 A. Chase and N. C. P. Cross, Clin. Cancer Res., 2011, 17, 2613.
37 A. Young, D. Mittal, J. Stagg and M. J. Smyth,
CancerDiscovery, 2014, 4, 879.
38 Biological activity data generated through the Open
Innovation Drug Discovery Program (OIDD) and screening
data were supplied courtesy of Eli Lilly and Company—
used with Eli Lilly's permission. To learn more about the
Lilly Open Innovation Drug Discovery program, please visit
the program website at https://openinnovation.lilly.com,
last accessed on 06-15-2016.
39 Biological activity data was generated employing a high
throughput screen based on primary blood mononuclear
cells (PMBCs) and using 10 mM of compound. The results
are reported as follows: compound number (% secretory
inhibition IL-5, % secretory inhibition IL-17, % PMBC cell
death). Diene 28 (7.8, 38.1, 3.9), bromide 30 (47.2, 3.8, 4.9),
ketopyran 31 (40.2, <2, 6.7), epoxide 36 (40.2, <2, 5.9). See
ESI and Table S1† for full details.
40 (a) S. H. Chang and C. Dong, Cell. Signalling, 2011, 23, 1069;
(b) T. Kouro and K. Takatsu, Int. Immunol., 2009, 21, 1303; (c)
D. L. Simmons, Drug Discovery Today, 2006, 11, 210.This journal is © The Royal Society of Chemistry 2017
